Try our Advanced Search for more refined results
March 21, 2012
Cubist Pharmaceuticals Inc. v. Hospira Inc.
Case Number:
1:12-cv-00367
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
December 08, 2014
Hospira Gets 4 Of 5 Cubicin Patents Nixed
A Delaware federal judge on Monday invalidated four Cubist Pharmaceuticals Inc. patents for its blockbuster Cubicin, an intravenous antibiotic used to treat skin and blood infections, potentially clearing the way for Hospira Inc. to sell a generic version in 2016.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login